Centennial Wealth Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$782K Buy
2,160
+59
+3% +$20.2K 0.17% 88
2026
Q1
$739K Buy
2,101
+81
+4% +$28.9K 0.18% 78
2025
Q4
$661K Buy
2,020
+12
+0.6% +$3.81K 0.17% 80
2025
Q3
$567K Buy
2,008
+352
+21% +$102K 0.16% 89
2025
Q2
$463K Buy
1,656
+117
+8% +$33.1K 0.15% 99
2025
Q1
$480K Buy
1,539
+192
+14% +$56.7K 0.17% 80
2024
Q4
$351K Buy
1,347
+83
+7% +$24.6K 0.14% 104
2024
Q3
$407K Buy
+1,264
New +$413K 0.16% 85

Other funds holding AMGN

Centennial Wealth Advisory's AMGN Position: Q2 2026 in Review

Centennial Wealth Advisory increased its Amgen (AMGN) stake by 2.8% in Q2 2026, buying an estimated $20.2K and bringing the position to 2,160 shares worth $782K. The position accounts for 0.17% of the portfolio, ranked #88.

Centennial Wealth Advisory first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Centennial Wealth Advisory held 2,160 shares of Amgen worth $782K as of Q2 2026.
  • Centennial Wealth Advisory bought 59 Amgen shares in Q2 2026, an estimated $20.2K.
  • Amgen made up 0.17% of Centennial Wealth Advisory's portfolio in Q2 2026, its #88 holding.
  • Centennial Wealth Advisory first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Centennial Wealth Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.